These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 6993602)
1. Biological significance of active and inactive renin in man. Lijnen P; Amery A; Fagard R; Verschueren L J Endocrinol; 1980 Apr; 85(1):137-43. PubMed ID: 6993602 [TBL] [Abstract][Full Text] [Related]
2. Biological significance of active and inactive renin in hypertensive patients. Lijnen P; Fagard R; Staessen J; Amery A Clin Exp Hypertens A; 1982; 4(11-12):2361-72. PubMed ID: 6756701 [TBL] [Abstract][Full Text] [Related]
3. Comparative study of an angiotensin-II analog and a converting enzyme inhibitor. Fagard RH; Amery AK; Lijnen PJ; Reybrouck TM Kidney Int; 1980 May; 17(5):647-53. PubMed ID: 6249956 [TBL] [Abstract][Full Text] [Related]
4. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping. Bing RF; Russell GI; Swales JD; Thurston H J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368 [TBL] [Abstract][Full Text] [Related]
5. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)]. Goto A Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):868-83. PubMed ID: 6997093 [TBL] [Abstract][Full Text] [Related]
6. Circulatory effects of renin-angiotensin system antagonists during halothane anaesthesia in hypertensive rats. Kaukinen S; Kataja J; Ylitalo P Acta Anaesthesiol Scand; 1983 Feb; 27(1):81-6. PubMed ID: 6340406 [TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effects of captopril and saralasin in essential and renal hypertension. Konrads A; Meurer KA; Hummerich W; Wambach G; Kindler J; Feltkamp H; Helber A Am J Cardiol; 1982 Apr; 49(6):1558-60. PubMed ID: 7041597 [TBL] [Abstract][Full Text] [Related]
8. Hypotensive action of captopril and saralasin in intact and anephric spontaneously hypertensive rats. Hutchinson JS; Mendelsohn FA; Doyle AE Hypertension; 1980; 2(2):119-24. PubMed ID: 6991407 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin II and renal hypertension in dog, rat and man: effect of converting enzyme inhibition. Atkinson AB; Brown JJ; Fraser R; Lever AF; Morton JJ; Riegger AJ; Robertson JI Clin Exp Hypertens (1978); 1980; 2(3-4):499-524. PubMed ID: 6253241 [TBL] [Abstract][Full Text] [Related]
10. Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure. Atkinson AB; Cumming AM; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI Br J Clin Pharmacol; 1982 Jun; 13(6):855-8. PubMed ID: 7046776 [TBL] [Abstract][Full Text] [Related]
11. Vasoactive peptides and hypertension: role of angiotensin converting enzyme. Johnston CI; Iansek R; Millar JA; McGrath BP; Matthews PG Aust N Z J Med; 1981; 11(Suppl 1):59-63. PubMed ID: 6266379 [TBL] [Abstract][Full Text] [Related]
12. Converting enzyme inhibition in mild and moderate essential hypertension. I. Acute effects on blood pressure, the renin-angiotensin system and blood bradykinin after a single dose of captopril. Rasmussen S; Leth A; Ibsen H; Damkjaer Nielsen M; Nielsen F; Giese J Acta Med Scand; 1985; 218(5):435-42. PubMed ID: 3004113 [TBL] [Abstract][Full Text] [Related]
13. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems. Ohman KP; Karlberg BE; Nilsson OR; Wettre S Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190 [TBL] [Abstract][Full Text] [Related]
15. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition. Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102 [TBL] [Abstract][Full Text] [Related]
16. Haemodynamic effects of captopril in hypertensive patients: comparison with saralasin. Fagard R; Amery A; Lijnen P; Reybrouck T Clin Sci (Lond); 1979 Dec; 57 Suppl 5():131s-134s. PubMed ID: 396066 [TBL] [Abstract][Full Text] [Related]
17. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis. Schroeder ET; Anderson GH; Goldman SH; Streeten DH Kidney Int; 1976 Jun; 9(6):511-9. PubMed ID: 940284 [TBL] [Abstract][Full Text] [Related]
18. Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system. Riegger GA; Steilner H; Hayduk K; Liebau G Am J Cardiol; 1982 Apr; 49(6):1555-7. PubMed ID: 6803566 [TBL] [Abstract][Full Text] [Related]
19. [Conversion of inactive renin to active renin following acute angiotensin converting enzyme inhibition in essential hypertension and renovascular hypertension]. Kutkuhn B; Chlebowski H; Hollenbeck M; Grabensee B Z Kardiol; 1989 Mar; 78(3):204-10. PubMed ID: 2652907 [TBL] [Abstract][Full Text] [Related]